相关产品推荐更多 >
万千商家帮你免费找货
0 人在求购买到急需产品
- 详细信息
- 文献和实验
- 技术资料
- 免疫原:
该BioSIM 抗人 SOST/Sclerostin 抗体 (罗莫索珠单抗 / 罗莫单抗),生物类似药,科研用途 [ CAS: 909395-70-6]的免疫原请参考该产品的说明书
- 保存条件:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 克隆性:
单克隆
- 适应物种:
Human
- 保质期:
为确保适当储存,请避免反复冻融。短期需求(1-2周)请在4°C下保存;最长12个月的储存请在-20°C下保存。长期储存请在-80°C下保存。
- 级别:
科研级别
- 库存:
999
- 供应商:
亚科因(Abbkine)
- 宿主:
Humanized
- 应用范围:
ELISA, FACS, Functional assay, Research in vivo
- 抗体英文名:
SOST/Sclerostin
- 抗体名:
SOST/Sclerostin
- 规格:
5mg
BioSIM 抗人 SOST/Sclerostin 抗体 (罗莫索珠单抗生物类似药)
产品概述
BioSIM 抗人 SOST/Sclerostin 抗体 (罗莫索珠单抗生物类似药) 是一种高质量的科研级二抗,专为骨质疏松症及相关骨代谢研究而设计。该产品作为罗莫索珠单抗的生物类似药,保留了与治疗性抗体相同的可变区结构,确保了研究应用中的特异性和可靠性。
产品特点
- 高特异性:精准靶向骨细胞分泌的硬化蛋白(SOST)
- 研究适用性:专为非治疗性科研应用设计
- 一致性:与治疗性Romosozumab具有相同的可变区
- 人源化:Humanized来源宿主,降低免疫原性
- 多应用支持:适用于多种实验方法
技术参数
| 产品名称 | BioSIM anti-Human SOST/Sclerostin Antibody (Romosozumab Biosimilar), Research Grade |
| CAS号 | 909395-70-6 |
| 产品类型 | 二抗 |
| 供应商 | InvivoCrown |
| 产品货号 | SIM0519-5mg |
| 产品规格 | 5mg |
| 来源宿主 | Humanized |
| 反应性 | Human |
作用机制
罗莫索珠单抗是一种靶向骨细胞分泌硬化蛋白(SOST)的人源化IgG2κ单克隆抗体。SOST通过结合LRP4/5/6并抑制Wnt/β-catenin信号通路(成骨细胞的关键信号通路)来负向调控骨形成。该生物类似药可中和SOST,从而促进骨形成并抑制骨吸收,为研究骨合成代谢机制、Wnt信号通路以及SOST在骨生物学中的功能提供了有力工具。
应用领域
- ELISA:酶联免疫吸附测定
- FACS:流式细胞术
- Functional assay:功能分析
- Research in vivo:体内研究
- 核心研究领域:骨质疏松症
保存与处理
为确保产品活性和稳定性,请遵循以下保存建议:
- 避免反复冻融:防止抗体活性下降
- 短期保存(1-2周):4°C
- 中期保存(最长12个月):-20°C
- 长期保存:-80°C
免疫原信息请参考产品说明书。
订购信息
| 产品货号 | 规格 | 供应商 |
| SIM0519-5mg | 5mg | InvivoCrown |
注意:以上信息可能随着产品优化升级等因素产生变动,具体信息请咨询亚科因公司。

BioSIM Anti-Human SOST/Sclerostin Antibody (Romosozumab Biosimilar)
Product Overview
BioSIM Anti-Human SOST/Sclerostin Antibody (Romosozumab Biosimilar) is a high-quality research-grade secondary antibody designed specifically for osteoporosis and related bone metabolism research. As a biosimilar of Romosozumab, this product retains the same variable region structure as the therapeutic antibody, ensuring specificity and reliability in research applications.
Product Features
- High Specificity: Precisely targets sclerostin (SOST) secreted by osteocytes
- Research Applicability: Designed specifically for non-therapeutic research applications
- Consistency: Same variable region as therapeutic Romosozumab
- Humanized: Humanized source host to reduce immunogenicity
- Multi-application Support: Suitable for various experimental methods
Technical Parameters
| Product Name | BioSIM anti-Human SOST/Sclerostin Antibody (Romosozumab Biosimilar), Research Grade |
| CAS Number | 909395-70-6 |
| Product Type | Secondary Antibody |
| Supplier | InvivoCrown |
| Catalog Number | SIM0519-5mg |
| Product Specification | 5mg |
| Source Host | Humanized |
| Reactivity | Human |
Mechanism of Action
Romosozumab is a humanized IgG2κ monoclonal antibody that targets sclerostin (SOST) secreted by osteocytes. SOST negatively regulates bone formation by binding to LRP4/5/6 and inhibiting the Wnt/β-catenin signaling pathway (a key signaling pathway for osteoblasts). This biosimilar can neutralize SOST, thereby promoting bone formation and inhibiting bone resorption, providing a powerful tool for studying anabolic bone mechanisms, Wnt signaling pathways, and the function of SOST in bone biology.
Application Areas
- ELISA: Enzyme-Linked Immunosorbent Assay
- FACS: Flow Cytometry
- Functional assay: Functional Analysis
- Research in vivo: In Vivo Research
- Core Research Areas: Osteoporosis
Storage and Handling
To ensure product activity and stability, please follow the storage recommendations below:
- Avoid repeated freeze-thaw cycles: Prevents decrease in antibody activity
- Short-term storage (1-2 weeks): 4°C
- Medium-term storage (up to 12 months): -20°C
- Long-term storage: -80°C
Please refer to the product manual for immunogenicity information.
Order Information
| Catalog Number | Specification | Supplier |
| SIM0519-5mg | 5mg | InvivoCrown |
Note: The information above may change due to factors such as product optimization and upgrades. For specific information, please consult Yaokein Company.
风险提示:丁香通仅作为第三方平台,为商家信息发布提供平台空间。用户咨询产品时请注意保护个人信息及财产安全,合理判断,谨慎选购商品,商家和用户对交易行为负责。对于医疗器械类产品,请先查证核实企业经营资质和医疗器械产品注册证情况。
文献和实验
技术资料暂无技术资料 索取技术资料





